Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is not yet recruiting in South Korea. It is testing theta Burst Stimulation Protocol of Repetitive Transcranial Magnetic Stimulation for treatment-resistant depression.
In Seoul
This study is not yet recruiting in China. It is testing Accelerated Intermittent Theta-burst Stimulation (a-iTBS) for depression.
In Chongqing
This study is not yet recruiting in Global. It is testing bupropion Hydrobromide for depression.
In GlobalThis study is not yet recruiting in Spain. It is testing daridorexant for depression.
In Barcelona
This study is not yet recruiting in Global. It focuses on depression.
In GlobalThis study is not yet recruiting in Bangladesh. It is testing paliperidone for schizophrenia.
In BarishalThis study is not yet recruiting in China. It is testing probiotics for depression.
In GuangzhouThis study is not yet recruiting in China. It is testing Transcranial Alternating Current Stimulation (tACS) Combined With Stable Medication for depression.
In ChongqingThis study is not yet recruiting in China. It is testing Transcranial Alternating Current Stimulation (tACS) for depression.
In ChongqingThis study is not yet recruiting in China. It is testing transcranial Temporal Interference Stimulation for depression.
In Nanjing
This study is not yet recruiting. It focuses on depression and currently lists study information in China.
In ShatinThis study is not yet recruiting in Global. It focuses on Anxiety.
In GlobalHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.